Diaceutics PLC (LON:DXRX) Insider Purchases £150.08 in Stock

Diaceutics PLC (LON:DXRX) insider Nick Roberts purchased 112 shares of the company’s stock in a transaction on Monday, September 30th. The shares were bought at an average cost of GBX 134 ($1.79) per share, with a total value of £150.08 ($200.75).

Nick Roberts also recently made the following trade(s):

• On Wednesday, August 28th, Nick Roberts bought 113 shares of Diaceutics stock. The stock was purchased at an average cost of GBX 134 ($1.79) per share, with a total value of £151.42 ($202.54).

Diaceutics Price Performance

Shares of LON:DXRX opened at GBX 133.99 ($1.79) on Wednesday. The company has a market cap of £113.18 million, a P/E ratio of -4,466.00 and a beta of 0.58. The business has a fifty day simple moving average of GBX 128.87 and a 200-day simple moving average of GBX 120.22. Diaceutics PLC has a 52 week low of GBX 82 ($1.10) and a 52 week high of GBX 136 ($1.82). The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 2.93.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group restated a “buy” rating and set a GBX 160 ($2.14) target price on shares of Diaceutics in a research report on Tuesday, September 17th.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.